This Article Full Text Full Text (PDF) All Versions of this Article: 106/2/214    most recent 01.CIR.0000021603.36744.5Ev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scott, A. C. Articles by Piepoli, M. F. Search for Related Content PubMed PubMed Citation Articles by Scott, A. C. Articles by Piepoli, M. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID LACTIC ACID Medline Plus Health Information Exercise for Children Exercise for Seniors Exercise and Physical Fitness Heart Failure Related Collections Congestive Exercise/exercise testing/rehabilitation

(Circulation. 2002;106:214.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure

A Putative Role for Prostaglandins in Reflex Ventilatory Control

Adam C. Scott, BSc; Roland Wensel, MD; Constantinos H. Davos, MD, PhD; Michael Kemp, MSc, MRCPath; Agnieszka Kaczmarek, MD; James Hooper, MD, FRCPath; Andrew J.S. Coats, DM, FRCP; Massimo F. Piepoli, MD, PhD

From the National Heart & Lung Institute, and Royal Brompton Hospital, Imperial College School of Science, Technology and Medicine, London, UK.

Correspondence to Massimo Piepoli, MD, PhD, Heart Failure Unit, Royal Brompton Hospital, Sydney St, London SW3 6NP, UK. E-mail m.piepoli{at}ic.ac.uk

Background— The overactivity of ergoreceptors (intramuscular afferents sensitive to products of skeletal muscle work) may be responsible for the abnormal responses to exercise and symptoms of exercise intolerance in chronic heart failure (CHF); however, little is known of the chemical nature of the stimuli involved. We investigated biochemical factors (H⁺, CO₂, O₂, HCO₃, K⁺, phosphate, lactate, PGE₂, PGF₁, and bradykinin) potentially involved in ergoreceptor activation.

Methods and Results— Sixteen stable patients with CHF (64.9±2.7 years, peak O₂ 15.8±0.7 mL/kg per min) and 10 age-matched controls were studied. The ergoreceptor test involved two 5-minute handgrip exercises. On one occasion, the subjects recovered normally (control recovery), whereas on the other a posthandgrip regional circulatory occlusion was induced in the exercising arm, isolating the stimulation of the ergoreceptor after exercise. The ergoreflex was quantified as the difference in ventilation between the posthandgrip regional circulatory occlusion and the control recovery periods. During the protocol, the local muscular blood effluent concentrations of metabolic mediators were assessed. Patients had an ergoreflex effect on ventilation greater than controls (4.8±1.4 versus 0.4±0.1 L/min, P<0.01). During the ergoreflex test in patients, the following metabolites were elevated with respect to resting values in comparison with controls: PGE₂ (3.7±0.7 versus 1.1±0.2 pg/mL), PGF₁ (16.2±2.8 versus 7.2±1.2 pg/mL), and bradykinin (2.1±0.3 versus 1.0±0.1 pg/mL), P<0.05 for all comparisons. Only the increases in prostaglandins were predictors of the ergoreflex response (r>0.41, P<0.01).

Conclusions— Although multiple metabolites are concentrated in exercising muscle in CHF, only prostaglandins correlated with ergoreflex activity, suggesting these factors as potential triggers to the exaggerated ergoreflex, which is characteristic of CHF. This may have important implications for novel therapies to improve exercise tolerance.

Key Words: exercise • muscles • ventilation

This article has been cited by other articles:

				S. Koba, Z. Gao, and L. I. Sinoway Oxidative stress and the muscle reflex in heart failure J. Physiol., November 1, 2009; 587(21): 5227 - 5237. [Abstract] [Full Text] [PDF]

				G. D. Lewis, R. V. Shah, P. P. Pappagianopolas, D. M. Systrom, and M. J. Semigran Determinants of Ventilatory Efficiency in Heart Failure: The Role of Right Ventricular Performance and Pulmonary Vascular Tone Circ Heart Fail, November 1, 2008; 1(4): 227 - 233. [Abstract] [Full Text] [PDF]

				A. Momen, J. Cui, P. McQuillan, and L. I. Sinoway Local prostaglandin blockade attenuates muscle mechanoreflex-mediated renal vasoconstriction during muscle stretch in humans Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2184 - H2190. [Abstract] [Full Text] [PDF]

				H. R. Middlekauff, J. Chiu, M. A. Hamilton, G. C. Fonarow, W. R. MacLellan, A. Hage, J. Moriguchi, and J. Patel Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1956 - H1962. [Abstract] [Full Text] [PDF]

				A. Houssiere, M. Gujic, G. Deboeck, A. Ciarka, R. Naeije, and P. van de Borne Increased metaboreflex activity is related to exercise intolerance in heart transplant patients Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3699 - H3706. [Abstract] [Full Text] [PDF]

				M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M. D. Guazzi Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2136 - 2144. [Abstract] [Full Text] [PDF]

				A. Crisafulli, E. Salis, F. Tocco, F. Melis, R. Milia, G. Pittau, M. A. Caria, R. Solinas, L. Meloni, P. Pagliaro, et al. Impaired central hemodynamic response and exaggerated vasoconstriction during muscle metaboreflex activation in heart failure patients Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2988 - H2996. [Abstract] [Full Text] [PDF]

				A. Houssiere, B. Najem, N. Cuylits, S. Cuypers, R. Naeije, and P. van de Borne Hyperoxia enhances metaboreflex sensitivity during static exercise in humans Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H210 - H215. [Abstract] [Full Text] [PDF]

				A. Houssiere, B. Najem, A. Ciarka, S. Velez-Roa, R. Naeije, and P. van de Borne Chemoreflex and metaboreflex control during static hypoxic exercise Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1724 - H1729. [Abstract] [Full Text] [PDF]

				H. R. Middlekauff, J. Chiu, M. A. Hamilton, G. C. Fonarow, W. R. MacLellan, A. Hage, J. Moriguchi, and J. Patel Muscle mechanoreceptor sensitivity in heart failure Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1937 - H1943. [Abstract] [Full Text] [PDF]

				H. R. Middlekauff and J. Chiu Cyclooxygenase products sensitize muscle mechanoreceptors in healthy humans Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1944 - H1949. [Abstract] [Full Text] [PDF]

				A. C. Scott, R. Wensel, C. H. Davos, P. Georgiadou, L. Ceri Davies, A. J.S. Coats, D. P. Francis, and M. F. Piepoli Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure Eur. Heart J., October 2, 2004; 25(20): 1806 - 1813. [Abstract] [Full Text] [PDF]

				K. K.A. Witte and A. L. Clark The effect of aspirin on the ventilatory response to exercise in chronic heart failure Eur J Heart Fail, October 1, 2004; 6(6): 745 - 748. [Abstract] [Full Text] [PDF]

				A. C. Scott, R. Wensel, C. H. Davos, P. Georgiadou, M. Kemp, J. Hooper, A. J.S. Coats, and M. F. Piepoli Skeletal Muscle Reflex in Heart Failure Patients: Role of Hydrogen Circulation, January 21, 2003; 107(2): 300 - 306. [Abstract] [Full Text] [PDF]